BIT Capital’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

BIT Capital’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-39,000	Closed	-$228K	–	194
2022 Q4	$228K	Sell	39,000 -19,000	-33%	-$99.9K	0.05%	111
2022 Q3	$389K	Buy	+58,000	New	+$352K	0.07%	90

BIT Capital's CNCE Position: Q1 2023 in Review

BIT Capital sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 39,000 shares — an estimated $228K sold.

BIT Capital first reported a position in CNCE in Q3 2022 and held it in 2 quarters. The position peaked at $389K in Q3 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

BIT Capital reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
BIT Capital sold 39,000 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $228K.
BIT Capital first reported a position in Concert Pharmaceuticals, Inc. in Q3 2022 and held it in 2 quarters.
BIT Capital's Concert Pharmaceuticals, Inc. position peaked at $389K in Q3 2022.
0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on BIT Capital's 13F filing for Q1 2023, filed 12 Feb 2025.